Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-03

Clinical Trial Update: Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the efficacy of Tenofovir Disoproxil in reducing mother-to-child transmission of hepatitis B virus in pregnant women …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tenofovir disoproxil (Tenofovir disoproxil)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Hepatitis B Virus - Chronic Active | Phase 4 | Status: UNKNOWN